Stockscreener 앱 받기
15.77
12.18%
1.73
전일 마감가:
$14.04
열려 있는:
$14.08
하루 거래량:
67,693
Relative Volume:
0.48
시가총액:
$647.20M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.42%
1개월 성능:
-27.79%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$14.08
$15.76
1주일 범위
$13.64
$16.55
52주 변동 폭
$13.64
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
BBNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
15.74 | 647.20M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
126.34 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.76 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.86 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.06 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.63 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-24 | 개시 | BofA Securities | Buy |
| 2025-02-24 | 개시 | Lake Street | Buy |
| 2025-02-24 | 개시 | Leerink Partners | Outperform |
| 2025-02-24 | 개시 | Piper Sandler | Overweight |
| 2025-02-24 | 개시 | Stifel | Buy |
| 2025-02-20 | 개시 | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 개시 | Robert W. Baird | Neutral |
모두보기
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Head to Head Survey: Arch Therapeutics (OTCMKTS:ARTH) & Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc.’s Quiet Period Will Expire on March 11th (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently - Yahoo Finance
10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - GlobeNewswire
Leerink Partnrs Comments on Beta Bionics FY2024 Earnings - Defense World
Beta Bionics, Inc. (NASDAQ:BBNX) Receives $20.00 Average PT from Brokerages - Defense World
Kestra Medical ups IPO target to $150M - BioWorld Online
Beta Bionics (NASDAQ:BBNX) Raised to Strong-Buy at Leerink Partnrs - Defense World
Beta Bionics initiated with a Buy at Lake Street - MSN
BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating - TradingView
Beta Bionics (NASDAQ:BBNX) Now Covered by Analysts at Leerink Partners - Defense World
Beta Bionics (NASDAQ:BBNX) Now Covered by Analysts at Piper Sandler - Defense World
BofA initiates Beta Bionics stock with Buy, sets $25 target - Investing.com India
BofA initiates Beta Bionics stock with Buy, sets $25 target By Investing.com - Investing.com South Africa
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wall Street bullish on insulin device maker Beta Bionics after IPO - TradingView
Leerink Partners sets $28 target for Beta Bionics stock By Investing.com - Investing.com South Africa
Leerink Partners sets $28 target for Beta Bionics stock - Investing.com India
Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target -February 24, 2025 at 07:15 am EST - Marketscreener.com
Stifel Initiates Beta Bionics at Buy With $25 Price Target -February 24, 2025 at 07:15 am EST - Marketscreener.com
Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target -February 24, 2025 at 07:11 am EST - Marketscreener.com
Piper Sandler sets Beta Bionics stock at overweight with $26 target By Investing.com - Investing.com South Africa
Piper Sandler sets Beta Bionics stock at overweight with $26 target - Investing.com India
Buy Recommendation for Beta Bionics: Leveraging Untapped Market Opportunities and Innovative Product Differentiation - TipRanks
Stifel initiates coverage on Beta Bionics stock with Buy rating, $25 target - Investing.com Australia
Stifel initiates coverage on Beta Bionics stock with Buy rating, $25 target By Investing.com - Investing.com South Africa
Beta Bionics rated new Neutral at Baird on valuation - MSN
Beta Bionics (NASDAQ:BBNX) Stock Rating Upgraded by Baird R W - Defense World
Beta Bionics (NASDAQ:BBNX) Coverage Initiated at LADENBURG THALM/SH SH - Defense World
Baird starts Beta Bionics stock with neutral, sets $20 target By Investing.com - Investing.com South Africa
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Beta Bionics stock rated new Neutral at Baird (BBNX:NASDAQ) - Seeking Alpha
Ladenburg starts Beta Bionics stock at Buy, sets $31 PT By Investing.com - Investing.com South Africa
Ladenburg starts Beta Bionics stock at Buy, sets $31 PT - Investing.com
Ladenburg Thalmann Initiates Beta Bionics at Buy With $31 Price Target -February 20, 2025 at 07:39 am EST - Marketscreener.com
Baird starts Beta Bionics stock with neutral, sets $20 target - Investing.com India
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing - MSN
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year LowShould You Sell? - MarketBeat
Beta Bionics (NASDAQ:BBNX) Trading Down 5.7%Here's Why - MarketBeat
Kestra files for $100M IPO - BioWorld Online
Beta Bionics (NASDAQ:BBNX) Sets New 12-Month Low – Time to Sell? - Defense World
Beta Bionics Debuts at Nearly $1B Value - Orange County Business Journal
Beta Bionics Inc (BBNX) 재무 분석
Beta Bionics Inc (BBNX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.57%
0.83%
자본화:
|
볼륨(24시간):